Author

H. Amatullah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:differential expression· 2 Assay:metagenomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Organism:mouse· 1

Frequent Co-Authors

F. Adiliaghdam· 2 shared I. Fraschilla· 2 shared K. L. Jeffrey· 2 shared L. P. Wong· 2 shared R. Sadreyev· 2 shared R.-U. Rahman· 2 shared S. Digumarthi· 2 shared G. Bonilla· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Adiliaghdam

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease

I. Fraschilla, H. Amatullah, R.-U. Rahman, K. Jeffrey

This study identifies SP140's role in regulating microbiota and preventing inflammatory bowel disease by controlling inflammatory bacteria.

bioRxiv · Mar 29, 2022Immunology

Human enteric viruses shape disease phenotype through divergent innate immunomodulation

F. Adiliaghdam, H. Amatullah, S. Digumarthi, T. L. Saunders, R.-U. Rahman, L. P. Wong, R. Sadreyev, L. Droit, J. Paquette, P. Goyette, J. Rioux, R. Hodin, K. Mihindukulasuriya, S. A. Handley, K. L. Jeffrey

The paper shows that human viromes from healthy and IBD patients differentially modulate innate immunity, influencing disease phenotypes through nucleic acid sensing.

bioRxiv · Oct 14, 2021 · PreprintImmunology

Identification of topoisomerase as a precision-medicine target in chromatin reader SP140-driven Crohns disease

H. Amatullah, S. Digumarthi, I. Fraschilla, F. Adiliaghdam, G. Bonilla, L. P. Wong, R. Sadreyev, K. L. Jeffrey

This study identifies SP140 as a repressor of topoisomerases in immune diseases and shows TOP inhibition can reverse SP140-driven pathology.

bioRxiv · Sep 20, 2021 · PreprintImmunology